X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4840) 4840
Book Chapter (88) 88
Magazine Article (33) 33
Newsletter (21) 21
Dissertation (10) 10
Publication (7) 7
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (3169) 3169
humans (3053) 3053
life sciences & biomedicine (2907) 2907
lactones - therapeutic use (2383) 2383
animals (1674) 1674
male (1524) 1524
female (1425) 1425
lactones - pharmacology (1082) 1082
pharmacology & pharmacy (1031) 1031
lactones (755) 755
middle aged (744) 744
adult (743) 743
lactones - adverse effects (729) 729
anti-obesity agents - therapeutic use (560) 560
mice (519) 519
aged (501) 501
lactones - chemistry (501) 501
sulfones (491) 491
obesity - drug therapy (485) 485
lactones - administration & dosage (464) 464
cyclooxygenase inhibitors - therapeutic use (434) 434
treatment outcome (405) 405
orlistat (396) 396
anti-inflammatory agents, non-steroidal - therapeutic use (393) 393
rats (392) 392
chemistry, medicinal (348) 348
chemistry (344) 344
abridged index medicus (341) 341
analysis (327) 327
research (324) 324
sulfones - therapeutic use (322) 322
celecoxib (312) 312
physical sciences (308) 308
double-blind method (299) 299
obesity (293) 293
oncology (293) 293
anti-inflammatory agents, non-steroidal - adverse effects (275) 275
rofecoxib (272) 272
dose-response relationship, drug (271) 271
cyclooxygenase inhibitors - adverse effects (266) 266
risk factors (261) 261
biochemistry & molecular biology (256) 256
care and treatment (249) 249
weight loss (248) 248
health aspects (247) 247
ivermectin (246) 246
sulfones - adverse effects (245) 245
cell line, tumor (244) 244
general & internal medicine (243) 243
sulfonamides - therapeutic use (242) 242
time factors (238) 238
medicine, general & internal (237) 237
adolescent (235) 235
cyclooxygenase 2 (231) 231
cyclooxygenase 2 inhibitors (225) 225
cancer (224) 224
drug therapy (219) 219
membrane proteins (205) 205
apoptosis (204) 204
cyclobutanes - therapeutic use (204) 204
sesquiterpenes - pharmacology (204) 204
clinical trials as topic (198) 198
plant extracts - pharmacology (193) 193
pyrazoles (192) 192
research article (189) 189
science & technology - other topics (189) 189
medicine (187) 187
apoptosis - drug effects (184) 184
randomized controlled trials as topic (182) 182
anthelmintics - therapeutic use (172) 172
drug therapy, combination (172) 172
antineoplastic agents - therapeutic use (171) 171
sulfonamides - adverse effects (170) 170
proteins (167) 167
medicine & public health (166) 166
body mass index (165) 165
cyclooxygenase 2 inhibitors - therapeutic use (165) 165
quorum sensing (165) 165
physiological aspects (163) 163
multidisciplinary sciences (162) 162
drug resistance (161) 161
sesquiterpene lactones (161) 161
macrolides (158) 158
anti-obesity agents - adverse effects (155) 155
microbiology (155) 155
pharmacology/toxicology (155) 155
drugs (152) 152
chemistry, multidisciplinary (151) 151
endocrinology & metabolism (150) 150
lactones - metabolism (150) 150
gene expression (149) 149
lipase - antagonists & inhibitors (149) 149
disease models, animal (146) 146
isoenzymes - antagonists & inhibitors (144) 144
spironolactone - therapeutic use (144) 144
inflammation (143) 143
rats, sprague-dawley (143) 143
parasitology (142) 142
plant sciences (142) 142
antineoplastic agents - pharmacology (141) 141
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4562) 4562
German (273) 273
Japanese (65) 65
French (61) 61
Russian (31) 31
Chinese (29) 29
Spanish (28) 28
Portuguese (15) 15
Italian (14) 14
Polish (10) 10
Swedish (7) 7
Danish (5) 5
Finnish (5) 5
Hungarian (5) 5
Czech (4) 4
Dutch (4) 4
Norwegian (4) 4
Turkish (3) 3
Croatian (2) 2
Hebrew (2) 2
Serbian (2) 2
Bulgarian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American heart journal, ISSN 0002-8703, 11/2014, Volume 168, Issue 5, pp. 611 - 621
.... Anticoagulation uses 1 of 4 choices: bivalirudin, unfractionated heparin, enoxaparin, and fondaparinux... 
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Recombinant Proteins - therapeutic use | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Hirudins | Humans | Heparin - therapeutic use | Enoxaparin - therapeutic use | Tyrosine - analogs & derivatives | Receptors, Thrombin - antagonists & inhibitors | Warfarin - therapeutic use | Tyrosine - therapeutic use | Adenosine - therapeutic use | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Anticoagulants - therapeutic use | Piperazines - therapeutic use | Adenosine Monophosphate - therapeutic use | Lactones - therapeutic use | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Adenosine Monophosphate - analogs & derivatives | Peptide Fragments - therapeutic use | Peptides - therapeutic use | Aspirin | Glycosaminoglycans | Atrial fibrillation | Mortality | Thrombin | Anticoagulants (Medicine) | Health aspects | Drug approval | Coronary heart disease | Heart attacks | Acute coronary syndromes | Drug therapy | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 05/2017, Volume 152, Issue 7, pp. 1765 - 1779
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2008, Volume 35, Issue 3, pp. 255 - 261
.... New, more effective microtubule-targeting agents continue to enter into clinical trials and some, including the epothilone ixapebilone, have been approved for use... 
Hematology, Oncology and Palliative Medicine | 2-Methoxyestradiol | Discodermolide | Microtubule-targeting agent | Epothilone | Halichondrin B | Microtubule | Taxane | Colchicine | Vinca alkaloid | Taccalonolide | Life Sciences & Biomedicine | Oncology | Science & Technology | Colchicine - pharmacology | Taxoids - pharmacology | Tubulin Modulators - pharmacology | Colchicine - therapeutic use | Humans | Epothilones - pharmacology | Epothilones - therapeutic use | Lactones - pharmacology | Drug Delivery Systems | Taxoids - therapeutic use | Neoplasms - genetics | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Microtubules - drug effects | Vinca Alkaloids - pharmacology | Microtubules - ultrastructure | Macrolides - pharmacology | Steroids - pharmacology | Steroids - therapeutic use | Antineoplastic Agents, Phytogenic - therapeutic use | Microtubules - physiology | Clinical Trials as Topic | Vinca Alkaloids - therapeutic use | Cell Division - drug effects | Lactones - therapeutic use | Tubulin Modulators - therapeutic use | Neoplasms - drug therapy | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Antineoplastic Agents, Phytogenic - pharmacology | Macrolides - therapeutic use | Neoplasms - pathology | Drug Screening Assays, Antitumor | Development and progression | Care and treatment | Leukemia | Analysis | Cancer | Index Medicus | Microtubule-Targeting Agent | Vinca Alkyloid
Journal Article